Experts at the National Institute of Allergy and Infectious Diseases (NIAID) have developed a system to help diagnose and treat common medical problems and develop personalized, personalized medicine, the agency said in a news release.
“The system includes a large database of immunology data, which has been downloaded over time and can be processed automatically,” the release said.
The NIAID released a white paper about its work with researchers at the University of California, Berkeley, and at the Massachusetts Institute of Technology.
The system is not yet ready for use in humans, but NIAIDS officials said it could soon be.
“We are working closely with the University at Berkeley and others to integrate this information into existing medical data systems, including the National Health and Nutrition Examination Survey (NHANES),” NIAIDs deputy director, Dr. Jennifer E. Smith, said in the news release, referring to the National Survey of Health and Aging.
“This work could lead to a new way of measuring, diagnosing and treating chronic disease and provides a platform for other researchers to conduct similar work.”
The research could also be applied to other diseases, such as cancer, and could help scientists better understand the molecular underpinnings of diseases.
“Using a predictive model that predicts the severity of a disease based on previous data, we are able to better diagnose diseases and treat them in ways that would not otherwise be possible,” Dr. Josephine Roesch, the lead author of the study and an NIAIS senior scientist, said.
She is a professor of infectious diseases at Stanford University.
She and her colleagues at Berkeley collaborated on the system, which is now being used by researchers at several universities and hospitals around the country.
The research was supported by the National Institutes of Health (grants R01MH099976 and R01CA06886).
The study was published in the journal Nature Immunology.